IranPharmis participated in the 6th Interventional Pain Congress 2025, held on December 26–27, 2024, at the Iran Mall International Complex in Tehran.
As one of the country’s leading medical companies, IranPharmis showcased its latest innovations in medical consumables and solutions for pain management.
The company’s active presence emphasized its ongoing commitment to scientific collaboration, technological advancement, and improving the quality of patient care in Iran’s healthcare system
The “6th Interventional Pain Congress” was held on December
26–27, 2024 (6–7 Dey 1403) at the Iran Mall International Complex in Tehran.
Recognized as one of the most important national scientific
gatherings in the field of pain management and minimally invasive therapies,
this event brought together leading experts and specialists from across the
country.
IranPharmis participated actively and effectively in the
congress, aiming to introduce its latest medical consumables and present its
innovative solutions in pain management.
This presence provided a valuable opportunity to interact
with top medical professionals, showcase the company’s latest achievements, and
highlight IranPharmis’ indigenous healthcare technologies.
The main focus of IranPharmis on Innovation and Scientific Collaboration
in Pain Management
With a scientific and forward-looking approach, IranPharmis
attended the congress to present its innovations in medical consumables to the
professional medical community.
The company’s goal was to exchange knowledge with pain
management specialists, strengthen research collaborations, and enhance the
quality of care for patients suffering from acute and chronic pain.
Relying on local technological development and international
quality standards, IranPharmis continues to advance its mission of improving
community health and optimizing therapeutic processes.
IranPharmis’ Activities and Achievements
During “the 6th Interventional Pain Congress”, IranPharmis
carried out a wide range of scientific and professional activities that drew
considerable attention from attendees and experts.
The company’s most notable actions and achievements
included:
- Introducing innovative
consumable products designed for minimally invasive pain management procedures.
- Organizing specialized meetings
and discussions with leading pain and anesthesiology experts to explore
clinical needs and exchange experiences.
- Providing educational
brochures and scientific guidelines on the optimal use of new medical
consumables.
- Establishing new
partnerships with healthcare centers, hospitals, and companies active in the
health sector.
- Participating in scientific
panels and lectures, where IranPharmis experts shared their latest findings and
innovative treatment solutions.
Interactions and Feedback
IranPharmis’ active participation in the congress fostered
extensive engagement with the country’s medical community.
Feedback from physicians and specialists reflected high
satisfaction with the quality, efficiency, and scientific design of IranPharmis’
consumables.
These positive reactions reaffirm the medical community’s
trust in IranPharmis and its position as one of the leading brands in Iran’s
medical consumables industry.
Future Outlook and Conclusion
By taking part in the 6th Interventional Pain Congress,
IranPharmis once again demonstrated its commitment to innovation, quality, and
scientific development within the national medical industry.
Looking ahead, the company aims to introduce even more
advanced products, expand its professional collaborations, and play an
increasingly active role in improving patient care quality and promoting public
health across the country.
for more
acquaintance with the specialized solutions in the field of medical equipment
, please visit the product page in our website.